Duey Marc — SEC Form 4 filings
SEC reporting owner CIK 1925150. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-21 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 51,649 shares, $157,190 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 6,462 shares, $29,583 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 30,000 shares @ $4.39 ($131,700) in Aprea Therapeutics, Inc., filed 2024-10-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | Director | 7 | 3 legs · 51,649 sh · $157,190 | 1 leg · 6,462 sh · $29,583 | 7 |
Form 4 filings — Duey Marc
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 3,135 @ $0 · Grant/award (A): 12,555 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 21,459 @ $1.17 · Purchase (P): 21,459 (derivative) | EDGAR |
| 2025-06-09 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
| 2024-10-25 | 4 | Aprea Therapeutics, Inc. (APRE) | Sale (S): 6,462 @ $4.58 | EDGAR |
| 2024-10-17 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 30,000 @ $4.39 | EDGAR |
| 2024-10-16 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 190 @ $2.58 | EDGAR |
| 2024-06-21 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1925150 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →